English
- استرجاع مجاني وسهل
- أفضل العروض
Clinical Trials: Study Design, Endpoints And Biomarkers, Drug Safety, And FDA And ICH Guidelines hardcover english - 26 Mar 2016
الآن:
466.95 د.إ.شامل ضريبة القيمة المضافة
باقي 2 وحدات في المخزون
احصل عليه خلال 28 ديسمبر
احصل على د.إ. 23.35 رصيد مسترجع باستخدام بطاقة بنك المشرق نون الائتمانية. اشترك الآن. قدّم الحين
ادفع على 4 دفعات بدون فوائد بقيمة ١١٦٫٧٤ د.إ.اعرف المزيد
قسمها على 4 دفعات ب ١١٦٫٧٤ د.إ. بدون فوائد أو رسوم تأخير.اعرف المزيد
1
توصيل مجاني لنقطة نون ومراكز الاستلام
معرفة المزيد
إرجاع سهل لكل المنتجات في هذا العرض.
المنتج كما في الوصف
50%
شريك لنون منذ
2+ سنينالمواصفات
| الناشر | Elsevier Science Publishing Co Inc |
| رقم الكتاب المعياري الدولي 13 | 9780128042175 |
| رقم الكتاب المعياري الدولي 10 | 128042176 |
| اللغة | الإنجليزية |
| العنوان الفرعي للكتاب | Study Design, Endpoints And Biomarkers, Drug Safety, And FDA And ICH Guidelines |
| وصف الكتاب | Clinical Trials, Second Edition, offers those engaged in clinical trial design a valuable and practical guide. This book takes an integrated approach to incorporate biomedical science, laboratory data of human study, endpoint specification, legal and regulatory aspects and much more with the fundamentals of clinical trial design. It provides an overview of the design options along with the specific details of trial design and offers guidance on how to make appropriate choices. Full of numerous examples and now containing actual decisions from FDA reviewers to better inform trial design, the 2nd edition of Clinical Trials is a must-have resource for early and mid-career researchers and clinicians who design and conduct clinical trials. |
| عن المؤلف | Dr. Tom Brody received his PhD from the University of California at Berkeley in 1980, and conducted postdoctoral research at University of Wisconsin-Madison and also at U.C. Berkeley. His 20 research publications concern the metabolism and pharmacology of folates, cloning an anti-cancer gene (XPE gene), and the structure of an antibody (natalizumab) used for treating multiple sclerosis. The author has 15 years of pharmaceutical industry experience, acquired at Schering-Plough, Cerus Corporation, and Elan Pharmaceuticals, and has contributed to FDA submissions for the indications of multiple sclerosis, melanoma, head and neck cancer, liver cancer, pancreatic cancer, and hepatitis C. At an earlier time, he wrote two editions of Clinical Trials, published by Elsevier, Inc. The author has 16 years of training and experience in the Code of Federal regulations, as it applies to pharmaceuticals and clinical trial design. |
| رقم الطبعة | 2 |
| تاريخ النشر | 26 Mar 2016 |
| عدد الصفحات | 896 |
Clinical Trials: Study Design, Endpoints And Biomarkers, Drug Safety, And FDA And ICH Guidelines hardcover english - 26 Mar 2016
تمت الإضافة لعربة التسوق
مجموع السلة 466.95 د.إ.
